Hemofarm to double capacities in Banja Luka

Hemofarm to double capacities in Banja Luka

Published at: 2019-08-28 09:39 | Author: CIJ Serbia
Since the beginning of 2019, Hemofarm has invested around €2m to expand its operations in Banja Luka. “There will be significant investments in the coming period towards doubling current capacities. In addition to investing in machinery and manufacturing processes, we also invest in environmental protection. About €1m has been invested in a state-of-the-art wastewater treatment plant and every year we invest additional funds to improve its performance,” said Sasa Urosevic, director of Hemofarm Banja Luka. The company, which is owned by Stada, was established in 2003. It currently employs 185 people and is a leading manufacturer on Bosnia’s drug and medicine market.

Similar Stories:

Building permit in place for Czech BMW testing center
BMW Group Mobility Development has secured a construction permit in Sokolovska in the Karl  »
Krones opens first plant in Hungary
Krones has opened a plant in Debrecen, eastern Hungary, following a HUF 15bn investment. T  »
Duocor completes HUF 3.2bn expansion of Hungarigan plant
Duocor has completed a HUF 3.2bn expansion of its production plant in Mako, southeastern H  »
Feka Automotive building factory in central Serbia
Feka Automotive broke ground on a factory in Cuprija, central Serbia. The 7,000 sqm facili  »
How does Bucharest’s investment market compare to Prague’s? There’s little compari   »
How much are you lending on infrastructure projects in Slovakia? How does it compare to ot   »
Should we believe people in the market when they say they’re working on five to six deal   »
Going into 2016, most observers assumed Czech retail assets would be a major investment ta   »